During a visit to the joint venture Biotech Pharma (BPL), established in the People’s Republic, Cuban Prime Minister Manuel Marrero praised the outcome of cooperation between his country and China in the field of biotechnology as a result of research on and the development and production of groundbreaking biomedical products.

Despite the impact by the US economic, commercial and financial blockade, the Cuban health system looks forward to improving services for the people.

Cuban doctors have given Mexican citizens affected by Hurricane Otis over 300 medical consultations in three hospitals and communities in Acapulco city, Guerrero state.

The National Association of Italy-Cuba Friendship ( ANAIC) donated 27,000 euros for research on a vaccine against dengue fever, by the Center for Genetic Engineering and Biotechnology (CIGB) of the Caribbean nation.

Cuban doctors joined their Mexican colleagues assisting the citizens affected by the passage of hurricane Otis on that sister nation.

A complex epidemiological scenario is prevailing in this eastern Cuban province marked by the proliferation of Aedes aegypti mosquitos and increasing number of Dengue cases.

The inauguration of the International Artificial Intelligence Research Institute in Hebei province, China, is a result of joint efforts between the People’s Republic and Cuba to promote academic and scientific cooperation, according to Cuban Minister of Higher Education Walter Baluja in his report about of a working visit to the cities of Shanghai and Hebei.

The Cuban COVID-19 vaccine Abdala, the first one developed and produced in Latin America, plays a key role in the nationwide vaccination program recently launched in Mexico.

The vaccine candidate Quimi-Vio, produced by the Finlay Vaccine Institute (IFV) for the treatment of pneumonia, meningitis, otitis and sepsis caused by Streptococcus pneumoniae or pneumococcus, entered clinical trials in Havana with children suffering from chronic diseases.

A greater number of patients with rheumatoid arthritis throughout the country are benefiting nowadays from the immunomodulatory and anti-inflammatory effects of the drug Jusvinza, which is in phase III of its clinical trial.

Renowned Latin American specialists are attending the 1st International Congress Odonto-Santiago 2023, held in the city of Santiago de Cuba and intended to enrich the culture of oral health and spread the existing knowledge about this field.

Pledged to maintain the excellence of university education, health workers in eastern Cuba attended a cultural gala to celebrate Latin American Dentistry Day and the 60th anniversary of the Stomatology School of the city of Santiago de Cuba.

During the 60th session of the PAHO Directing Council in Washington, U.S.A., Cuban Minister of Public Health José Ángel Portal and PAHO director Jarbas Barbosa da Silva signed the Country Cooperation Strategy to carry out joint work in the next five years (2023-2027).

Presided over by the Cuban Head of State Miguel Díaz-Canel, the weekly meeting of government leaders with health care scientists reviewed the results of interferon use in the COVID-19 Action Protocol and highlighted the capacity of Cuban science and health system to resort to provenly effective products such as interferons to prevent and fight new diseases.